Back to Rankings

PHIO

PhioB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
PHIO vs peer average
84/100
PHIO vs. peer average (B vs. D)
Grade spread
A 1 · C 1 · D 3 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AKTX is the first available peer comparator.

Microcap biotech peer useful mainly for comparing financing sensitivity and binary development-event volatility; operating overlap with PHIO is limited.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAKTXAkari Therapeutics
PHIO
Phio
AKTX
Akari Therapeutics
Grade
B
F
Momentum
87
40
Value
58
42
Sentiment
39
26
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs AKTX

PHIO / AKTX
Grade Position
Above peers
PHIO vs. peer average (B vs. D)
84/100
Momentum
87
PHIO
Value
58
PHIO
Sentiment
39
PHIO

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PHIO
1
AKTX
AKTX
F
20/100
+3
2
GDTC
GDTC
D
40/100
+2
3
KPRX
KPRX
D
40/100
+2
4
BCDA
BioCardia Inc Common
D
40/100
+2
5
BIVI
BioVie Inc Class A Common
F
20/100
+3
AKTX is the first peer returned for this comparison set.